Gabelli Funds’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Gabelli Funds’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-325,700	Closed	-$43M	–	1276
2025 Q1	$43M	Buy	+325,700	New	+$40.6M	0.33%	72

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gabelli Funds's ITCI Position: Q2 2025 in Review

Gabelli Funds sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 325,700 shares — an estimated $43M sold.

Gabelli Funds first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $43M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Gabelli Funds reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Gabelli Funds sold 325,700 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $43M.
Gabelli Funds first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
Gabelli Funds's Intra-Cellular Therapies Inc. position peaked at $43M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.